New Zealand markets open in 8 hours 8 minutes
  • NZX 50

    -49.52 (-0.42%)

    +0.0012 (+0.20%)

    +35.90 (+0.45%)
  • OIL

    -0.33 (-0.40%)
  • GOLD

    -15.20 (-0.65%)

West to Participate in Upcoming Investor Conferences

EXTON, Pa., Feb. 28, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Barclays 26th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 12, 2024, at 1:05 PM ET.

(PRNewsfoto/West Pharmaceutical Services, I)
(PRNewsfoto/West Pharmaceutical Services, I)

It will also present at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 9:00 AM ET.

A live audio webcast of each event will be available in the "Investors" section of the Company's website at Replay of the webcasts will be available for approximately 90 days after the events.


About West 

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 48 billion components and devices each year.

Headquartered in Exton, Pennsylvania, West in its fiscal year 2023 generated $2.95 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.


View original content to download multimedia:

SOURCE West Pharmaceutical Services, Inc.